Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group
Lancet. 2011 378 (9789): 412-9

PMID: 21719096 · PMCID: PMC3462593 · DOI:10.1016/S0140-6736(11)60886-6

MeSH Terms (16)

Abatacept Adolescent Adult Autoimmunity Child Diabetes Mellitus, Type 1 Double-Blind Method Female Humans Immunoconjugates Immunosuppressive Agents Insulin-Secreting Cells Male Randomized Controlled Trials as Topic T-Lymphocytes Young Adult

Connections (2)

This publication is referenced by other Labnodes entities:

Links